Human ALK protein tyrosine kinase
US5770421A · kind A · utility
35Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 12, 1995 |
| Grant date | Jun 23, 1998 |
| Priority date | — |
| Expiry date | Oct 12, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/81
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention is based on the identification and sequence determination of a novel gene, ALK, which is fused to the gene encoding nucleophosmin (NPM) in translocations present in t(2;5) lymphoma cells. Based on homologies to other proteins, the amino acid sequence of the polypeptide encoded by the ALK (Anaplastic Lymphoma Kinase) gene is a membrane-spanning protein tyrosine kinase (PTK)/receptor. Antibodies to the ALK PTK/receptor and methods utilizing such antibodies are described, as are methods of using the ALK gene to isolate ligands for the ALK PTK/receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.